Radiation
CAN-2409 + Chemoradiation/SBRT for Pancreatic Cancer
Recruiting1 awardPhase 2
Fort Myers, Florida
This trial is testing a new immunotherapy treatment for pancreatic cancer that has shown promise in earlier trials. The new treatment will be given in combination with standard chemotherapy and radiation, and the goal is to see if it improves outcomes for patients with pancreatic cancer.
CAR T-cell Therapy
Engineered T Cells + Pembrolizumab for Pleural Cancer
Recruiting1 awardPhase 1 & 2
Basking Ridge, New Jersey
This trial is testing the safety of different doses of modified T cells for patients with malignant pleural disease. They will also test the combination of the T cells with another drug, pembrolizumab, to see what effect it has on the cancer.
Cancer Vaccine
Tumor Cell Vaccine + Cytoxan for Neuroblastoma
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing an experimental treatment for neuroblastoma, which is a solid tumor that is the second most common cancer in children. The treatment consists of a series of immunizations using a tumor vaccine, combined with low-dose chemotherapy taken by mouth on a daily basis. The hope is that the vaccine will cause the immune system to recognize and kill more types of neuroblastoma tumors. Additionally, the immunizations will be combined with daily low dose chemotherapy.
Popular Filters
Trials With No Placebo
Immunotherapy
N-803 + BCG for Bladder Cancer
Recruiting1 awardPhase 2 & 3
Anchorage, Alaska
This trial is testing a new drug, N-803, for people with bladder cancer that has not responded to BCG treatment. Patients will receive the new drug through a urinary catheter weekly for 6 weeks, followed by maintenance treatment every 3 or 6 weeks for up to 3 years.
CAR T-cell Therapy
CAR T Cell Therapy for Lymphoma
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing whether it's more effective to give patients with lymphoma genetically modified T cells that have been combined with an antibody, after they've received chemotherapy to decrease the level of circulating T cells.
CAR T-cell Therapy
T-Cell Therapy for Breast Cancer
Recruiting1 awardPhase 1
Basking Ridge, New Jersey
This trial is testing the safety of different doses of T cells that have been collected from the blood and modified to target HER2-negative breast cancer cells. The goal is to find a safe dose of these modified T cells that can be used to treat patients with metastatic breast cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.